Antibacterial Activities of Persimmon Roots-derived Materials and 1,4-Naphthoquinone's Derivatives against Intestinal Bacteria

  • Kim, Hyung-Wook (Department of Bioenvironmental Chemistry, College of Agriculture & Life Science, Chonbuk National University) ;
  • Lee, Chi-Hoon (Department of Bioenvironmental Chemistry, College of Agriculture & Life Science, Chonbuk National University) ;
  • Lee, Hoi-Seon (Department of Bioenvironmental Chemistry, College of Agriculture & Life Science, Chonbuk National University)
  • Published : 2009.06.30

Abstract

The growth-inhibiting activities of persimmon roots-derived materials against intestinal bacteria were evaluated and compared with that of 1,4-naphthoquinone as a positive control. The active constituent isolated from persimmon roots was characterized as 5-hydroxy-2-methyl-1,4-naphthoquinone using various spectroscopic analyses. Treatment with 1,4-naphthoquinone at a dose of 1.0 mg/disc strongly inhibited the growth of 6 intestinal bacteria. Furthermore, when the structure-activity relationships of 1,4-naphthoquinone's derivatives were evaluated, 5-hydroxy-2-methyl-1,4-naphthoquinone and 2-methyl-1,4-naphthoquinone were found to strongly inhibit the growth of Clostridium difficile, Clostridium perfringens, and Escherichia coli without adversely affecting the growth of Bifidobacterium adolescentis, Bifidobacterium longum, and Lactobacillus acidophilus. Additionally, 2-hydroxy-1,4-naphthoquinone and 5-hydroxy-1,4-naphthoquinone strongly inhibited the growth of C. difficile and C. perfringens, but did not inhibit the growth of E. coli. Taken together, these results indicate that persimmon roots-derived materials and some of 1,4-naphthoquinone's derivatives could be useful preventive agents against diseases caused by harmful intestinal bacteria.

Keywords

References

  1. Macfarlane S, Macfarlance GT. Food and the large intestine. pp. 24-51. In: Gut Flora, Nutrition, Immunity, and Health. Fuller R, Perdigon G (eds). Blackwell Publishing Press, Oxford, UK (2003)
  2. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22: 283-307 (2002) https://doi.org/10.1146/annurev.nutr.22.011602.092259
  3. Hall MA, Cole CB, Smith SI, Fuller R, Rolles CJ. Factors influencing the presence of faecal lactobacilli in early infancy. Arch. Dis. Child. 65: 185-188 (1990) https://doi.org/10.1136/adc.65.2.185
  4. Finegold SM. Anaerobic infections in humans: An overview. Anaerobe 1: 3-9 (1995) https://doi.org/10.1016/S1075-9964(95)80340-8
  5. Jung SM, Choi SI, Park SM, Heo TR. Synergistic antimicrobial effect of Achyranthes japonica Nakai extracts and Bifidobacterium supernatants against Clostridium difficile. Food Sci. Biotechnol. 17: 402-407 (2008)
  6. Hentges DJ. Role of the intestinal microflora in host defense against infection. pp. 311-331. In: Human Intestinal Microflora in Health and Disease. Hentges DJ (ed). Academic Press, New York, NY, USA (1983)
  7. World Health Organization. Use of antimicrobials outside human medicine and resultant antimicrobial resistance in humans. Available from: http://www.who.int/mediacentre/factsheets/fs268/en/. Accessed Apr. 17, 2008.
  8. Sorum H, Sunde M. Resistance to antibiotices in the normal flora of animals. Vet. Res. 32: 227-241 (2001) https://doi.org/10.1051/vetres:2001121
  9. Choi SI, Hong EY, Lee JH, Lee YS, Kim GH. Antioxidant and antimicrobial activities of the ethanol extract of Allium victoriallis L. var. platyphyllum. Food Sci. Biotechnol. 17: 313-318 (2008)
  10. Sibanda T, Okoh AI. The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents. Afr. J. Biotechn. 6: 2886-2896 (2007)
  11. An BJ, Bae MJ, Choi HJ, Zhang YB, Sung TS, Choi C. Natural products, organic chemistry: Isolation of polyphenol compounds from the leaves of Korean persimmon (Diospyrus kaki L. Folium). J. Korean Soc. Agric. Chem. Biotechnol. 45: 212-217 (2002)
  12. Mallavadhani UV, Panda AK, Rao YR. Pharmacology and chemotaxonomy of Diospyros. Phytochemistry 49: 901-951 (1998) https://doi.org/10.1016/S0031-9422(97)01020-0
  13. Tangmouo JG, Melia AL, Komguema J, Kueteb V, Ngounoua FN, Lontsia D, Beng VP, Choudharyc MI, Sondengama BL. Crassiflorone, a new naphthoquinone from Diospyros crassiflora (Hien). Tetrahedron Lett. 47: 3067-3070 (2006) https://doi.org/10.1016/j.tetlet.2006.03.006
  14. Lee CH, Lee HS. Acaricidal activity and function of mite indicator using plumbagin and its derivatives isolated from Diospyros kaki Thunb. Roots (Ebenaceae). J. Microbiol. Biotechn. 18: 314-321 (2008)
  15. Adeniyi BA, Fong HHS, Pezzuto JM, Luyengi L, Odelola HA. Antibacterial activity of diospyrin, isodiospyrin, and bisisodiospyrin from the root of Diospyros piscatoria (Gurke) (Ebenaceae). Phytother. Res. 14: 112-117 (2000) https://doi.org/10.1002/(SICI)1099-1573(200003)14:2<112::AID-PTR488>3.0.CO;2-T
  16. Ganapaty S, Thomas PS, Fotso S, Laatsch H. Antitermitic quinine from Diospyros sylvatica. Phytochemistry 65: 1265-1271 (2004) https://doi.org/10.1016/j.phytochem.2004.03.011
  17. Kawase M, Motohashi N, Satoh K, Sakagami H, Nakashima H, Tani S, Shirataki Y, Kurihara T, Spengler G, Wolfard K, Molnar J. Biological activity of persimmon (Diospyros kaki) peel extracts. Phytother. Res. 17: 495-500 (2003) https://doi.org/10.1002/ptr.1183
  18. Sung BK, Kim MK, Lee WH, Lee DH, Lee HS. Growth responses of Cassia obtusifolia toward human intestinal bacteria. Fitoterapia 75: 505-509 (2004) https://doi.org/10.1016/j.fitote.2004.03.012
  19. Vishnu KT, Ravindra VS, Dharmendra BY. Synthesis and evalution of novel 1,4-naphthoquinone derivatives as antiviral, antifungal, and anticancer agents. Bioorg. Med. Chem. 14: 2901-2904 (2004) https://doi.org/10.1016/j.bmcl.2004.03.047
  20. Hatzigrigoriou E, Papadopoulou MV, Shields D, Bloomer WD. 2-Alkyl-sulfonyloxy-3-hydroxy-1,4-naphthoquinones. A novel class of radio- and chemosensitizers of V79 cells. Oncol. Res. 5: 29-36 (1993)
  21. Kessl JJ, Meshnick SR, Trumpower BL. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi. Trends. Parasitol. 23: 494-501 (2007) https://doi.org/10.1016/j.pt.2007.08.004
  22. Michiko T, Masanori K, Kunitishi Y, Shinsaku N. Naphthoquinone derivatives from the Ebenaceae. IV. Naphthoquinone derivatives from Diospyros kaki Thunb. and D. kaki Thunb. var. sylvestris MAKINO. Chem. Pharm. Bull. 20: 2029-2035 (1972) https://doi.org/10.1248/cpb.20.2029
  23. Ohmori K, Kitamura M, Ishikawa Y, Kato H, Oorui M, Suzuki K. Semi-pinacol strategy for constructing B-ring of pradimicinbenanomicin antibiotics. Tetrahedon Lett. 43: 7023-7026 (2002) https://doi.org/10.1016/S0040-4039(02)01608-8
  24. Omura S, Tanaka H, Koyama Y, Oiwa R, Katagiri M, Hata T. Nanaomycins A and B, new antibiotics produced by a strain of Streptomyces. J. Antibiot. 27: 363-365 (1974) https://doi.org/10.7164/antibiotics.27.363
  25. Park BS, Kim JR, Lee SE, Kim KS, Takeoka GR, Ahn YJ, Kim JH. Selective growth-inhibiting effects of compounds Tabebuia impetiginosa inner bark on human intestinal bacteria identified intestinal bacteria. J. Agr. Food Chem. 53: 1152-1157 (2005) https://doi.org/10.1021/jf0486038
  26. Chemin LS, Buisine E, Yardly V, Kohler S, Debreu MA, Landry V, Sergheraert C, Croft SL, Siegel RLK, Charvet ED. 2- and 3-Substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: Synthesis and correlation between redox cycling activities and in vitro cytotoxicity. J. Med. Chem. 44: 548-565 (2001) https://doi.org/10.1021/jm001079l
  27. Tran T, Saheba E, Arcerio V, Chavez, Li Q, Martinez LE, Primm TP. Quinones as antimycobacterial agents. Bioorg. Med. Chem. 12: 4809-4813 (2004) https://doi.org/10.1016/j.bmc.2004.07.015
  28. Lim MY, Jeon JH, Jeong EY, Lee CH, Lee HS. Antimicrobial activity of 5-hydroxy-1,4-naphthoquinone isolated from Caesalpinia sappan toward intestinal bacteria. Food Chem. 100: 1254-1258 (2007) https://doi.org/10.1016/j.foodchem.2005.12.009